Technology: Drug Delivery, Stem cell therapy
Industry: Gene therapy, Public
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2016-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 9
Total Funding: 267800000
Estimated Revenue: $10M to $50M
Last Funding Date: 2022-12-07
Last Funding Type: Post-IPO Equity

Visit Website
info@vorbiopharma.com
Register and Claim Ownership